QuVa Pharma

Sugar Land, United Stateswww.onequva.com1expert edge

Leading 503B outsourced sterile compounding pharmacy service provider operating five state-of-the-art facilities across the US, serving hospitals nationwide with ready-to-administer injectable medications.

Why interesting to a deal team

Bain Capital board representation since 2018 indicates PE backing and interest in pharmacy services. Demonstrates consolidation opportunities in hospital pharmaceutical supply chain and distribution.

Experts connected to this company

Andrew KaplanBain Capital board representative, quoted on 2018 funding round

Andrew Kaplan

Partner, Healthcare

Bain Capital

Fund GPBoston

Kaplan is a lead Bain Capital healthcare dealmaker actively deploying capital into pharma services/CDMO platforms like PCI Pharma, making him a key read on deal terms and sector appetite.

Sources

Structured dataPrimary
onequva.com
Page titlePress
prnewswire.com/news-releases/quva-pharma-completes-275-million-financing-with-syndicate-led-by-goldman-sachs-301285581.html

Strongest evidenceStructured data2 public sourcesHow the grades work